Revitalist Lifestyle and Wellness Ltd. Stock Canadian Securities Exchange

Stocks

CALM

CA76151T1030

Healthcare Facilities & Services

OTC Markets Traded
Delayed Canadian Securities Exchange 5-day change 1st Jan Change
- CAD -.--% Intraday chart for Revitalist Lifestyle and Wellness Ltd. -.--% -

Valuation: Revitalist Lifestyle and Wellness Ltd.

Market Cap 2.97M 2.6M 2.4M 2.24M 4.22M 281M 4.31M 28.87M 11.15M 138M 11.15M 10.9M 481M P/E 2021
-0.83x
P/E 2022 -0.12x
Enterprise Value 12.77M 11.18M 10.32M 9.64M 18.15M 1.21B 18.56M 124M 47.96M 596M 47.97M 46.91M 2.07B EV / Sales 2021
6,424,266x
EV / Sales 2022 369,034x
Free-Float
98.18%
Yield 2021 *
-
Yield 2022 -
5 years 0
Extreme 0
0.88
10 years 0
Extreme 0
0.88
Manager TitleAgeSince
Chief Operating Officer - 2023-03-29
Sales & Marketing - -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 137
-0.24%+2.76%+50.91%+51.39% 133B
-0.26%+3.39%+1.74%+29.73% 86.89B
-0.95%-0.25%-7.59%+58.27% 25.58B
-0.47%+7.93%+16.31%+48.03% 23.23B
-0.85%-3.65%-20.44%-26.28% 19.83B
-1.14%+4.26%+5.89%+128.28% 16.28B
+0.14%+2.75%-1.86%+7.12% 14.78B
-0.10%+3.09%+51.74%+118.71% 13.93B
-3.18%-4.10%-18.68%-8.30% 12.52B
Average -0.67%+3.72%+8.67%+45.22% 38.46B
Weighted average by Cap. -0.46%+4.63%+20.98%+44.06%

Financials

2021 2022
Net sales 2.07 1.81 1.67 1.56 2.94 195.47 3 20.11 7.76 96.43 7.76 7.59 334.8 4.57 4 3.69 3.45 6.49 431.6 6.63 44.41 17.14 212.93 17.14 16.77 739.25
Net income -12.61M -11.04M -10.19M -9.52M -17.92M -1.19B -18.33M -123M -47.35M -588M -47.35M -46.31M -2.04B -13.63M -11.93M -11.02M -10.29M -19.37M -1.29B -19.81M -133M -51.18M -636M -51.18M -50.06M -2.21B
Net Debt 1.6 1.4 1.29 1.21 2.27 151.14 2.32 15.55 6 74.56 6 5.87 258.87 9.8 8.58 7.93 7.4 13.93 926.95 14.25 95.37 36.82 457.3 36.82 36.01 1.59K
Logo Revitalist Lifestyle and Wellness Ltd.
Revitalist Lifestyle and Wellness Ltd. is a mental health and wellness company focused on comprehensive care in the ketamine wellness space. The Company, through its Tennessee subsidiary, Revitalist LLC, operates physical locations in three states, virtual offices across six states and medical and behavioral services in two countries. The Company’s segments include Clinical Operations and Research. The Clinical Operations segment encompasses the Company’s ketamine assisted psychotherapy clinics across the United States. The Research segment consists of the development of virtual clinics in the metaverse and research focused expenses. The Company offers various therapies, such as Ketamine Therapy, Home Ketamine Therapy, Ketamine Assisted Psychotherapy, Spravato, Vitamin Therapy, Neuropeptide Therapy and Supplements. It offers treatment for various conditions, including Anxiety, Depression, PTSD, OCD, Bipolar Disorder, Pain, Suicidal Ideation and Substance Abuse.
Employees
-